Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells

被引:33
|
作者
Skrtic, S
Wallenius, V
Ekberg, S
Brenzel, A
Gressner, AM
Jansson, JO
机构
[1] Sahlgrens Univ Hosp, Res Ctr Endocrinol & Metab, Div Endocrine, S-41345 Gothenburg, Sweden
[2] Univ Marburg, Dept Clin Chem, D-3550 Marburg, Germany
[3] RWTH Univ Hosp, Cent Lab, Inst Clin Chem & Pathobiochem, Aachen, Germany
关键词
conditioned medium; insulin-like growth factor-1; in vitro; paracrine; rat;
D O I
10.1016/S0168-8278(99)80015-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Hepatic stellate cells appear to be the main producers of hepatocyte growth factor of the normal liver. Insulin-like growth factors in doses over 20 ng/ml have been reported to stimulate hepatocyte growth factor production in cultured hepatic stellate cells. The aim of the present study was to investigate whether parenchymal cell conditioned medium had insulin-like growth factor-independent effects on hepatic stellate cells. Methods: Primary rat hepatic stellate cells were cultured for 1-7 days. DNA synthesis was measured by H-3-thymidine incorporation. Hepatocyte growth factor and transforming growth factor beta(1) immunoreactivity was quantified by ELISA. Hepatocyte growth factor mRNA levels were determined with gel RNase protection assay. Parenchymal cell conditioned medium was obtained from hepatocytes cultured for 2 days in medium without added serum or hormones. Results: Incubation of 1-7-day-old hepatic stellate cells for 2 days with parenchymal cell conditioned medium enhanced the medium content of hepatocyte growth factor. Parenchymal cell conditioned medium contained less than 5.0 ng/ml immunoreactive insulin-like growth factor-1 as measured by radio immunoassay. Parenchymal cell conditioned medium did not contain any insulin-like growth factor bioactivity measured as phosphorylation of type 1 insulinlike growth factor receptor beta subunit and a protein with a size consistent with that of insulin receptor substrate-1. The stimulatory effect of parenchymal cell conditioned medium on hepatocyte growth factor was time- and dose-dependent. The effects of a high dose of parenchymal cell conditioned medium (dilution 1:2 containing less than 2.5 ng/ml insulin-like growth factor-1) were additive to that of high doses (100 ng/ml) of insulin-like growth factor-1 or des (1-3) insulin-like growth factor-1, an analogue with low affinity to insulin-like growth factor binding proteins. Neither parenchymal cell conditioned medium nor insulin-like growth factor-1 enhanced transforming growth factor beta(1) immunoreactivity in the medium. Both parenchymal cell conditioned medium and insulin-like growth factor-1 stimulated DNA synthesis in hepatic stellate cells, confirming previous reports. Conclusions: The present results indicate that both insulin-like growth factor-1 and insulin-like growth factor-1-independent factors from hepatocytes can stimulate hepatocyte growth factor production by hepatic stellate cells. Therefore, insulin-like growth factor-1 and other hepatocyte-derived factors may indirectly affect hepatocytes via a paracrine loop.
引用
收藏
页码:115 / 124
页数:10
相关论文
共 50 条
  • [41] A preparative regimen of hepatic irradiation and hepatocyte growth factor (HGF) expression for liver repopulation by transplanted hepatocytes.
    Guha, C
    Yamanouchi, K
    Mohan, S
    Liu, LB
    Lee, SW
    Thumalla, NR
    Roy-Chowdhury, N
    Ray-Chowdhury, J
    HEPATOLOGY, 2004, 40 (04) : 382A - 382A
  • [42] HEPATOCYTE GROWTH-FACTOR (HGF) IS NOT A RENAL MORPHOGEN
    AVNER, ED
    SWEENEY, WE
    CLINICAL RESEARCH, 1993, 41 (02): : A332 - A332
  • [43] EXPRESSION OF HEPATOCYTE GROWTH-FACTOR (HGF) IN HUMAN GASTRIC-ULCER
    TAKAHASHI, M
    OTA, S
    OGURA, K
    HAMADA, E
    SHIMADA, T
    TERANO, A
    GASTROENTEROLOGY, 1995, 108 (04) : A755 - A755
  • [44] Hepatocyte growth factor (HGF) measurement in AL amyloidosis
    Desport, E.
    Abraham, J.
    Marin, B.
    Bender, S.
    Lacombe, C.
    Yagoubi, F.
    Lavergne, D.
    Bridoux, F.
    Jaccard, A.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 189 - 190
  • [45] Human hepatocyte growth factor (HGF) in the aqueous humor
    Araki-Sasaki, K
    Danjo, S
    Kawaguchi, S
    Hosohata, J
    Tano, Y
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1997, 41 (06) : 409 - 413
  • [46] Hepatocyte growth factor (HGF) in human aqueous humor
    Ritch, R
    Lippes, J
    Hu, DN
    Galvao, R
    Srivasthana, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S677 - S677
  • [47] Hepatocyte growth factor (HGF) and proliferative vitreoretinal disease
    Heathcote, LE
    Grierson, I
    Hiscott, P
    Wong, D
    Groenewald, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U89 - U89
  • [48] Therapeutic angiogenesis using hepatocyte growth factor (HGF)
    Morishita, R
    Aoki, M
    Hashiya, N
    Yamasaki, K
    Kurinami, H
    Shimizu, S
    Makino, H
    Takesya, Y
    Azuma, J
    Ogihara, T
    CURRENT GENE THERAPY, 2004, 4 (02) : 199 - 206
  • [49] Maintenance of hepatocyte functions in coculture with hepatic stellate cells
    Higashiyama, S
    Noda, M
    Muraoka, S
    Uyama, N
    Kawada, N
    Ide, T
    Kawase, M
    Yagi, K
    BIOCHEMICAL ENGINEERING JOURNAL, 2004, 20 (2-3) : 113 - 118
  • [50] Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells
    Moriyama, T
    Kataoka, H
    Seguchi, K
    Tsubouchi, H
    Koono, M
    INTERNATIONAL JOURNAL OF CANCER, 1996, 66 (05) : 678 - 685